2021-11-16-世界卫生组织-Cervical_cancer_Uzbekistan_2021_country_profile_1页_64kb

Morbidity and Mortality: Cervical cancer incidence in Uzbekistan was 11.3 per 100,000 women in 2020 (age-standardized 11), with a cumulative risk of 1.2% among ages 0-74. Deaths in 2019 totaled 840, giving a mortality-to-incidence ratio of 0.58. A population-based cancer registry exists.

Primary Prevention: HPV vaccination is included in the national program, with a 2% coverage rate among 9-14-year-old girls in 2019 and 1% coverage by age 15. Introduction year and scale not specified; risk factors include low tobacco use (1.2%, women age 15+), variable condom use, and low HIV incidence (0.58 per 1000).

Secondary Prevention: No national screening program exists as of 2021. Among women ages 30-49, 13% have been screened in the last five years; sampling indicates poor screening uptake (e.g., 11% overall, graph shows low adherence).

Treatment and Supportive Care: National guidelines exist for cervical cancer management. Limited resources include few radiotherapy units (2 per 10,000 patients in 2017) and staffing gaps (e.g., no data for oncologists or medical physicists). Cancer centers at tertiary level available, but data not complete for specialized personnel.

WHO Strategy: Targets for 2030 include elimination; data shows low vaccine coverage (2% in 2019), no widespread screening, and disparities in outcome treatments. National population female is 16,530,000, with 78,100 female deaths in 2019.